Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding RiskMasato Nakamura, Shigeru Saito, Hiroyoshi Yokoi et al.|Circulation Journal|2021Cited by 12
Ischemic and Bleeding Events in PENDULUM Patients With High Bleeding Risk and High Platelet ReactivityRaisuke Iijima, Masato Nakamura, Kazushige Kadota et al.|Circulation Journal|2021Cited by 11
Comparison of Prasugrel and Clopidogrel in Thrombotic Stroke Patients with Risk Factors for Ischemic Stroke Recurrence: An Integrated Analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-IIITakanari Kitazono, Kazumi Kimura, Masahiro Kamouchi et al.|Cerebrovascular Diseases|2023Cited by 10
Early P2Y<sub>12</sub> Inhibitor Single Antiplatelet Therapy for High-Bleeding Risk Patients After Stenting ― PENDULUM Mono 24-Month Analysis ―Yoshihisa Nakagawa, Masato Nakamura, Kazushige Kadota et al.|Circulation Journal|2022Cited by 7
Clinical Outcomes After Percutaneous Coronary Intervention in East Asian Patients ― 30-Month Results of the PENDULUM Registry ―Kazushige Kadota, Masato Nakamura, Kōichi Nakao et al.|Circulation Journal|2022Cited by 6